Negating Economic Fatalism in U.S. Health Expenditure

posted by David W. Johnson on October 28, 2014

Found in US, categorized in Healthcare

Tags: 4sight Health; Healthcare; Reform; Obamacare;

Report Cover


Inefficient health expenditure is not America's destiny.


Government experts just published 2013-2023 projections for U.S. national health expenditure.  After five years below 4%, CMS forecasts roughly 6.0% annualized growth resulting in whopping healthcare expenditures totaling $5.2 trillion in 2023, representing 19.3 percent of GDP.

These projections embody an economic fatalism that insists healthcare expenditures will always consume a greater percentage of the U.S. economy. Inefficient health expenditure is not our destiny. The government’s analysis neglects a fundamental shift in healthcare supply-demand relationships driven by market demands for more productivity, transparency and value. 

About David W. Johnson

David W. Johnson

Dave is the CEO and founder of 4Sight Health, a healthcare boutique specializing in thought capital, strategic advisory services and venture investing.  4Sight Health operates at the intersection of healthcare economics, strategy and capital formation. The company’s four-stage analytic (Assess. Align. Adapt. Advance.) reflects the bottom-up, evolutionary character of disruptive, market-driven reform.  Mr. Johnson speaks frequently, authors a widely-read blog on market-driven healthcare reform and is currently writing Market versus Medicine: America’s Battle for Better Healthcare at Lower Prices that will publish in 2015.

Request a speaking engagement